600285 羚锐制药
已收盘 05-15 15:00:00
资讯
新帖
简况
羚锐制药05月14日获主力加仓1490.3万元
市场透视 · 05-14 07:20
羚锐制药05月14日获主力加仓1490.3万元
羚锐制药05月13日主力净流入388.0万元 散户资金抛售
市场透视 · 05-13 07:19
羚锐制药05月13日主力净流入388.0万元 散户资金抛售
羚锐制药05月09日主力净流入1211.3万元 散户资金抛售
市场透视 · 05-09
羚锐制药05月09日主力净流入1211.3万元 散户资金抛售
羚锐制药05月08日主力净流出921.0万元 散户资金买入
市场透视 · 05-08
羚锐制药05月08日主力净流出921.0万元 散户资金买入
开源证券给予羚锐制药买入评级,公司信息更新报告:2024年利润增长亮眼,“研发+并购”丰富产品矩阵
每日经济新闻 · 05-02
开源证券给予羚锐制药买入评级,公司信息更新报告:2024年利润增长亮眼,“研发+并购”丰富产品矩阵
羚锐制药04月29日主力净流入626万元 散户资金抛售
市场透视 · 04-29
羚锐制药04月29日主力净流入626万元 散户资金抛售
社保基金大举扫货 一季度增持72只个股(附名单)
中国基金报 · 04-28
社保基金大举扫货 一季度增持72只个股(附名单)
羚锐制药:业绩符合预期 看好银谷新动能
浙商证券 · 04-27
羚锐制药:业绩符合预期 看好银谷新动能
羚锐制药2025年一季报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 04-26
羚锐制药2025年一季报简析:营收净利润同比双双增长,盈利能力上升
羚锐制药(600285)3月31日股东户数3.63万户,较上期减少0.41%
证券之星 · 04-26
羚锐制药(600285)3月31日股东户数3.63万户,较上期减少0.41%
羚锐制药(600285.SH)发布一季度业绩,归母净利润2.17亿元,同比增长13.89%
智通财经 · 04-25
羚锐制药(600285.SH)发布一季度业绩,归母净利润2.17亿元,同比增长13.89%
羚锐制药2024年归母净利润增长27.2%至7.23亿元
财中社 · 04-25
羚锐制药2024年归母净利润增长27.2%至7.23亿元
羚锐制药拟每股派发现金红利0.9元
财中社 · 04-25
羚锐制药拟每股派发现金红利0.9元
羚锐制药:2024年净利润7.23亿元,同比增长27.19%
格隆汇资讯 · 04-25
羚锐制药:2024年净利润7.23亿元,同比增长27.19%
羚锐制药04月25日遭主力抛售1553万元
市场透视 · 04-25
羚锐制药04月25日遭主力抛售1553万元
羚锐制药04月23日遭主力抛售252万元
市场透视 · 04-23
羚锐制药04月23日遭主力抛售252万元
羚锐制药04月21日遭主力抛售470万元
市场透视 · 04-21
羚锐制药04月21日遭主力抛售470万元
羚锐制药04月17日获主力加仓403万元
市场透视 · 04-17
羚锐制药04月17日获主力加仓403万元
羚锐制药04月15日获主力加仓377万元
市场透视 · 04-15
羚锐制药04月15日获主力加仓377万元
羚锐制药03月10日主力净流入65万元 散户资金抛售
市场透视 · 03-10
羚锐制药03月10日主力净流入65万元 散户资金抛售
加载更多
公司概况
公司名称:
河南羚锐制药股份有限公司
所属行业:
医药制造业
上市日期:
2000-10-18
主营业务:
河南羚锐制药股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是贴剂、片剂、胶囊剂、软膏剂、其他。公司入选“2023年度中国医药工业百强企业”榜,荣登“2023年度中国中药企业TOP100排行榜”、“2024中成药工业综合竞争力50强”榜。
发行价格:
8.30
{"stockData":{"symbol":"600285","market":"SH","secType":"STK","nameCN":"羚锐制药","latestPrice":23.85,"timestamp":1747292400000,"preClose":23.88,"halted":0,"volume":4532100,"delay":0,"changeRate":-0.0013,"floatShares":566000000,"shares":567000000,"eps":1.3208,"marketStatus":"已收盘","change":-0.03,"latestTime":"05-15 15:00:00","open":23.78,"high":24.15,"low":23.75,"amount":109000000,"amplitude":0.0168,"askPrice":23.86,"askSize":2,"bidPrice":23.85,"bidSize":97,"shortable":0,"etf":0,"ttmEps":1.3208,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747359000000},"marketStatusCode":5,"adr":0,"adjPreClose":23.88,"symbolType":"stock","openAndCloseTimeList":[[1747272600000,1747279800000],[1747285200000,1747292400000]],"highLimit":26.27,"lowLimit":21.49,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":567115486,"isCdr":false,"pbRate":4.08,"roa":"--","peRate":18.057238,"roe":"6.81%","epsLYR":1.287,"committee":0.157407,"marketValue":13526000000,"turnoverRate":0.008,"status":1,"floatMarketCap":13496000000},"requestUrl":"/m/hq/s/600285","defaultTab":"news","newsList":[{"id":"2535012460","title":"羚锐制药05月14日获主力加仓1490.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535012460","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535012460?lang=zh_cn&edition=full","pubTime":"2025-05-14 15:20","pubTimestamp":1747207204,"startTime":"0","endTime":"0","summary":"05月14日, 羚锐制药股价涨1.96%,报收23.88元,成交金额1.7亿元,换手率1.25%,振幅3.80%,量比1.58。羚锐制药今日主力资金净流入1490.3万元,上一交易日主力净流入388.0万元。该股近5个交易日上涨2.98%,主力资金累计净流入1867.7万元;近20日主力资金累计净流出1432.6万元,其中净流出天数为10日。|05月14日主力加仓幅度排名||#|股票简称|主力净额占比|#|中集环科|14.76%|#|襄阳轴承|6.23%|#|跨境通|5.97%|#|...|...|#812|羚锐制药|0.11%|羚锐制药所在的中药Ⅱ行业,今日主力净流出8005万元,行业排名51/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514165438a6deb0ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514165438a6deb0ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600285","BK0070","BK0188","BK0077","BK0239"],"gpt_icon":0},{"id":"2535746611","title":"羚锐制药05月13日主力净流入388.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2535746611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535746611?lang=zh_cn&edition=full","pubTime":"2025-05-13 15:19","pubTimestamp":1747120777,"startTime":"0","endTime":"0","summary":"05月13日, 羚锐制药股价涨1.08%,报收23.42元,成交金额1.1亿元,换手率0.87%,振幅2.20%,量比1.05。羚锐制药今日主力资金净流入388.0万元,上一交易日主力净流出300.9万元。该股近5个交易日上涨0.95%,主力资金累计净流入491.0万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出3558.8万元,其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513162906a47c698a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513162906a47c698a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600285","BK0077","BK0239","BK0188","BK0070"],"gpt_icon":0},{"id":"2534178435","title":"羚锐制药05月09日主力净流入1211.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2534178435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534178435?lang=zh_cn&edition=full","pubTime":"2025-05-09 15:19","pubTimestamp":1746775177,"startTime":"0","endTime":"0","summary":"05月09日, 羚锐制药股价涨1.61%,报收23.29元,成交金额1.2亿元,换手率0.88%,振幅1.88%,量比0.92。羚锐制药今日主力资金净流入1211.3万元,上一交易日主力净流出921.0万元。该股近5个交易日下跌0.04%,主力资金累计净流入277.1万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出3908.8万元,其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509164108a477e0f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509164108a477e0f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","BK0188","600285","BK0239","BK0070"],"gpt_icon":0},{"id":"2533797987","title":"羚锐制药05月08日主力净流出921.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2533797987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533797987?lang=zh_cn&edition=full","pubTime":"2025-05-08 15:19","pubTimestamp":1746688759,"startTime":"0","endTime":"0","summary":"05月08日, 羚锐制药股价跌1.16%,报收22.92元,成交金额9390.9万元,换手率0.72%,振幅1.94%,量比0.56。羚锐制药今日主力资金净流出921.0万元,上一交易日主力净流入113.6万元。该股近5个交易日下跌0.48%,主力资金累计净流出308.0万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出8119.5万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508162334a6d758e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508162334a6d758e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","600285","BK0188","BK0239","BK0077"],"gpt_icon":0},{"id":"2532859035","title":"开源证券给予羚锐制药买入评级,公司信息更新报告:2024年利润增长亮眼,“研发+并购”丰富产品矩阵","url":"https://stock-news.laohu8.com/highlight/detail?id=2532859035","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532859035?lang=zh_cn&edition=full","pubTime":"2025-05-02 09:35","pubTimestamp":1746149737,"startTime":"0","endTime":"0","summary":"开源证券05月01日发布研报称,给予羚锐制药(600285.SH)买入评级。评级理由主要包括:1)贴剂、片剂及胶囊剂营收稳健提升,软膏剂小幅承压;2)研发、并购双引擎驱动,产品线持续补充丰富。风险提示:市场竞争加剧,产品销售不及预期,新产品研发进程不及预期。AI点评:羚锐制药近一个月获得2份券商研报关注,买入1家。文章来源:每日经济新闻原标题:开源证券给予羚锐制药买入评级,公司信息更新报告:2024年利润增长亮眼,“研发+并购”丰富产品矩阵","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502093907a46f7d8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502093907a46f7d8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600285","161027"],"gpt_icon":0},{"id":"2531927919","title":"羚锐制药04月29日主力净流入626万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2531927919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531927919?lang=zh_cn&edition=full","pubTime":"2025-04-29 15:19","pubTimestamp":1745911146,"startTime":"0","endTime":"0","summary":"04月29日, 羚锐制药股价涨1.17%,报收23.30元,成交金额1.8亿元,换手率1.35%,振幅1.65%,量比1.15。羚锐制药今日主力资金净流入626万元,上一交易日主力净流出2909万元。该股近5个交易日上涨2.55%,主力资金累计净流出4409万元;近20日主力资金累计净流出1.7亿元,其中净流出天数为14日。|04月29日主力加仓幅度排名||#|股票简称|主力净额占比|#|红墙股份|7.84%|#|塞力医疗|6.27%|#|东珠生态|5.34%|#|...|...|#1380|羚锐制药|0.05%|羚锐制药所在的中药Ⅱ行业,今日主力净流出1.66亿元,行业排名25/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429160010a6cce2ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429160010a6cce2ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","600285","BK0188","BK0070","BK0077"],"gpt_icon":0},{"id":"2530236320","title":"社保基金大举扫货 一季度增持72只个股(附名单)","url":"https://stock-news.laohu8.com/highlight/detail?id=2530236320","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530236320?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:52","pubTimestamp":1745848366,"startTime":"0","endTime":"0","summary":"东方财富Choice数据显示,上述324家公司累计获社保基金重仓持股54.97亿股,对应持股市值为853.85亿元。其中,宝钢股份获全国社保基金一一四组合新进买入1.58亿股,对应持仓市值为11.4亿元,占流通股比例为0.73%,暂时位列新进个股持有市值首位。增持72只个股增持方面,今年一季度社保基金加仓了中国巨石、鱼跃医疗、亿联网络、广联达、山金国际、国药股份、天山铝业等72只个股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821413697489104&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821413697489104&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["601918","688087","603979","BK0188","600389","BK0028","601677","600176","BK0175","BK0010","600310","605196","BK0164","688122","600256","600750","BK0235","600426","600970","BK0187","603889","BK0196","605183","600285","600452","600988","BK0082","600060","600511","600803","603848","603456","159982","603351","399300","600529","603067","601128"],"gpt_icon":0},{"id":"2530544798","title":"羚锐制药:业绩符合预期 看好银谷新动能","url":"https://stock-news.laohu8.com/highlight/detail?id=2530544798","media":"浙商证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530544798?lang=zh_cn&edition=full","pubTime":"2025-04-28 00:00","pubTimestamp":1745769600,"startTime":"0","endTime":"0","summary":"公司本季度完成银谷制药的股权交割,银谷制药纳入公司合并范围。公司本次收购银谷制药契合公司战略规划,补充了具有较高技术门槛的鼻喷剂、吸入剂等外用制剂剂型,进一步丰富公司产品矩阵。维持“买入”评级。考虑到公司具有较强的品牌价值和营销改革带来的渠道优势,2024 年限制性股票激励计划和员工持股计划落地增强业绩确定性,维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428155125a46a15b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428155125a46a15b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0077","BK0239","BK0070","600285"],"gpt_icon":0},{"id":"2530172803","title":"羚锐制药2025年一季报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2530172803","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530172803?lang=zh_cn&edition=full","pubTime":"2025-04-27 06:03","pubTimestamp":1745705027,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期羚锐制药发布2025年一季报。截至本报告期末,公司营业总收入10.21亿元,同比上升12.29%,归母净利润2.17亿元,同比上升13.89%。本报告期羚锐制药盈利能力上升,毛利率同比增幅1.55%,净利率同比增幅1.41%。去年的净利率为20.64%,算上全部成本后,公司产品或服务的附加值高。持有羚锐制药最多的基金为广发稳健回报混合A,目前规模为35.99亿元,最新净值0.7801,较上一交易日上涨0.05%,近一年下跌2.16%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427060515a6c9b1b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427060515a6c9b1b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600285"],"gpt_icon":0},{"id":"2530144630","title":"羚锐制药(600285)3月31日股东户数3.63万户,较上期减少0.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530144630","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530144630?lang=zh_cn&edition=full","pubTime":"2025-04-26 16:59","pubTimestamp":1745657974,"startTime":"0","endTime":"0","summary":"证券之星消息,近日羚锐制药披露,截至2025年3月31日公司股东户数为3.63万户,较12月31日减少150.0户,减幅为0.41%。在中药行业个股中,羚锐制药股东户数低于行业平均水平,截至3月31日,中药行业平均股东户数为5.21万户。从股价来看,2024年12月31日至2025年3月31日,羚锐制药区间跌幅为4.87%,在此期间股东户数减少150.0户,减幅为0.41%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042600010796.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600285","BK0188","BK0070","BK0239"],"gpt_icon":0},{"id":"2530918508","title":"羚锐制药(600285.SH)发布一季度业绩,归母净利润2.17亿元,同比增长13.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530918508","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530918508?lang=zh_cn&edition=full","pubTime":"2025-04-25 19:10","pubTimestamp":1745579443,"startTime":"0","endTime":"0","summary":"智通财经APP讯,羚锐制药(600285.SH)发布2025年第一季度报告,公司第一季度营业收入10.21亿元,同比增长12.29%;归属于上市公司股东的净利润2.17亿元,同比增长13.89%;归属于上市公司股东的扣除非经常性损益的净利润2.04亿元,同比增长12.38%;基本每股收益0.383元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1285216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600285"],"gpt_icon":0},{"id":"2530041299","title":"羚锐制药2024年归母净利润增长27.2%至7.23亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530041299","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530041299?lang=zh_cn&edition=full","pubTime":"2025-04-25 17:44","pubTimestamp":1745574274,"startTime":"0","endTime":"0","summary":"4月25日,羚锐制药公布2024年年报,公司营业收入为35.0亿元,同比上升5.7%;归母净利润为7.23亿元,同比上升27.2%;扣非归母净利润为6.42亿元,同比上升20.2%;经营现金流净额为8.76亿元,同比增长7.7%;EPS为1.2741元。截至四季度末,公司总资产50.17亿元,较上年度末增长5.1%;归母净资产为30.73亿元,较上年度末增长10.1%。公司在2024年度报告中强调了其经营情况的显著改善和创新发展。文章来源:财中社羚锐制药2024年归母净利润增长27.2%至7.23亿元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425175928a6c7dcfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425175928a6c7dcfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600285"],"gpt_icon":0},{"id":"2530904125","title":"羚锐制药拟每股派发现金红利0.9元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530904125","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530904125?lang=zh_cn&edition=full","pubTime":"2025-04-25 17:44","pubTimestamp":1745574273,"startTime":"0","endTime":"0","summary":"4月25日,羚锐制药(600285)发布公告,公司拟向全体股东每股派发现金红利0.9元(含税),预计总派发金额为5.1亿元,占归母净利润的70.64%。文章来源:财中社原标题:羚锐制药拟每股派发现金红利0.9元","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425180041a466a293&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425180041a466a293&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0077","BK0239","600285","BK0188"],"gpt_icon":0},{"id":"2530909288","title":"羚锐制药:2024年净利润7.23亿元,同比增长27.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530909288","media":"格隆汇资讯","labels":["viewpoints"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530909288?lang=zh_cn&edition=full","pubTime":"2025-04-25 17:30","pubTimestamp":1745573431,"startTime":"0","endTime":"0","summary":"格隆汇4月25日丨羚锐制药(600285.SH)公布2024年年度报告,报告期实现营业收入35.01亿元,同比增长5.72%;归属于上市公司股东的净利润7.23亿元,同比增长27.19%;基本每股收益1.287元。公司拟向全体股东每股派发现金红利0.90元(含税)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504251730429744d10f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504251730429744d10f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"羚锐制药:2024年净利润7.23亿元,同比增长27.19%","news_tag":"viewpoints","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600285"],"gpt_icon":0},{"id":"2530397550","title":"羚锐制药04月25日遭主力抛售1553万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530397550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530397550?lang=zh_cn&edition=full","pubTime":"2025-04-25 15:19","pubTimestamp":1745565560,"startTime":"0","endTime":"0","summary":"04月25日, 羚锐制药股价跌2.10%,报收21.92元,成交金额1.14亿元,换手率0.91%,振幅2.64%,量比1.22。羚锐制药今日主力资金净流出1553万元,连续6日净流出,上一交易日主力净流出323万元。|04月25日主力加仓幅度排名||#|股票简称|主力净额占比|#|N众捷汽车|25.80%|#|天元智能|12.79%|#|九洲集团|10.34%|#|...|...|#4232|羚锐制药|-0.13%|羚锐制药所在的中药Ⅱ行业,今日主力净流出6225万元,行业排名51/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425153841a466746e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425153841a466746e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0239","600285","BK0070","BK0077"],"gpt_icon":0},{"id":"2529523121","title":"羚锐制药04月23日遭主力抛售252万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529523121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529523121?lang=zh_cn&edition=full","pubTime":"2025-04-23 15:19","pubTimestamp":1745392794,"startTime":"0","endTime":"0","summary":"04月23日, 羚锐制药股价跌2.42%,报收22.17元,成交金额1.64亿元,换手率1.30%,振幅3.30%,量比1.98。羚锐制药今日主力资金净流出252万元,连续4日净流出,上一交易日主力净流出396万元。该股近5个交易日下跌3.44%,主力资金累计净流出769万元;近20日主力资金累计净流出1.26亿元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423155434a463936e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423155434a463936e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","600285","BK0070","BK0188","BK0239"],"gpt_icon":0},{"id":"2529684010","title":"羚锐制药04月21日遭主力抛售470万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529684010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529684010?lang=zh_cn&edition=full","pubTime":"2025-04-21 15:19","pubTimestamp":1745219949,"startTime":"0","endTime":"0","summary":"04月21日, 羚锐制药股价跌0.13%,报收22.78元,成交金额8940万元,换手率0.69%,振幅1.40%,量比0.84。羚锐制药今日主力资金净流出470万元,上一交易日主力净流出56万元。|04月21日主力加仓幅度排名||#|股票简称|主力净额占比|#|青岛金王|9.86%|#|阳光乳业|9.01%|#|新金路|6.41%|#|...|...|#3592|羚锐制药|-0.04%|羚锐制药所在的中药Ⅱ行业,今日主力净流出1.25亿元,行业排名19/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421154058a6c1fac7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421154058a6c1fac7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600285","BK0239","BK0077","BK0070","BK0188"],"gpt_icon":0},{"id":"2528636857","title":"羚锐制药04月17日获主力加仓403万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528636857","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528636857?lang=zh_cn&edition=full","pubTime":"2025-04-17 15:19","pubTimestamp":1744874376,"startTime":"0","endTime":"0","summary":"04月17日,羚锐制药股价收平报22.96元,成交金额7885万元,换手率0.61%,振幅1.39%,量比0.56。羚锐制药今日主力资金净流入403万元,连续4日净流入,上一交易日主力净流入1008万元。近一年数据显示,该股主力连续4日净流入后,次日上涨概率为33.33%,平均涨幅为3.05%。该股近5个交易日上涨1.10%,主力资金累计净流入1405万元,其中2个交易日为股价下跌时净流入;近20日主力资金累计净流出1.16亿元,其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417154525a45c26e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417154525a45c26e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","BK0239","BK0188","600285","BK0077"],"gpt_icon":0},{"id":"2527561468","title":"羚锐制药04月15日获主力加仓377万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527561468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527561468?lang=zh_cn&edition=full","pubTime":"2025-04-15 15:21","pubTimestamp":1744701683,"startTime":"0","endTime":"0","summary":"04月15日, 羚锐制药股价涨2.77%,报收22.99元,成交金额1.62亿元,换手率1.26%,振幅3.49%,量比0.81。羚锐制药今日主力资金净流入377万元,上一交易日主力净流入253万元。|04月15日主力加仓幅度排名||#|股票简称|主力净额占比|#|N信凯科技|23.75%|#|三态股份|8.94%|#|新亚电缆|8.44%|#|...|...|#1319|羚锐制药|0.03%|羚锐制药所在的中药Ⅱ行业,今日主力净流出1.11亿元,行业排名57/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415163417a6baf9a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415163417a6baf9a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","BK0239","600285","BK0188","BK0070"],"gpt_icon":0},{"id":"2518213070","title":"羚锐制药03月10日主力净流入65万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2518213070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518213070?lang=zh_cn&edition=full","pubTime":"2025-03-10 15:22","pubTimestamp":1741591341,"startTime":"0","endTime":"0","summary":"03月10日, 羚锐制药股价涨1.92%,报收20.68元,成交金额1.57亿元,换手率1.34%,振幅2.17%,量比1.12。羚锐制药今日主力资金净流入65万元,上一交易日主力净流出1515万元。该股近5个交易日下跌0.29%,主力资金累计净流出1288万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出1.24亿元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310164539a269b340&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310164539a269b340&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0070","600285","BK0188","BK0077","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1747337273749,"stockEarnings":[{"period":"1week","weight":0.0406},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.1401},{"period":"6month","weight":0.1062},{"period":"1year","weight":-0.04},{"period":"ytd","weight":0.0763}],"compareEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.0346},{"period":"3month","weight":0.0102},{"period":"6month","weight":0.015},{"period":"1year","weight":0.0836},{"period":"ytd","weight":0.0087}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"河南羚锐制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"36288人(较上一季度减少0.41%)","perCapita":"15593股","listingDate":"2000-10-18","address":"河南省信阳市新县将军路666号","registeredCapital":"56711万元","survey":" 河南羚锐制药股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是贴剂、片剂、胶囊剂、软膏剂、其他。公司入选“2023年度中国医药工业百强企业”榜,荣登“2023年度中国中药企业TOP100排行榜”、“2024中成药工业综合竞争力50强”榜。","listedPrice":8.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"羚锐制药(600285)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供羚锐制药(600285)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"羚锐制药,600285,羚锐制药股票,羚锐制药股票老虎,羚锐制药股票老虎国际,羚锐制药行情,羚锐制药股票行情,羚锐制药股价,羚锐制药股市,羚锐制药股票价格,羚锐制药股票交易,羚锐制药股票购买,羚锐制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"羚锐制药(600285)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供羚锐制药(600285)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}